ReviewPharmaceuticals (Basel, Switzerland)2022

Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4.

Pratibha Pandey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.